Valeant Pharmaceuticals International Strategic Accounts Manager Salaries in Wilmington, DE
The average Valeant Pharmaceuticals International Strategic Accounts Manager in Wilmington, DE earns an estimated $129,600 annually. Valeant Pharmaceuticals International's Strategic Accounts Manager compensation is $14,551,735 less than the US average for a Strategic Accounts Manager.
In Wilmington, DE, The Business Development Department at Valeant Pharmaceuticals International earns $871 more on average than the Marketing Department.
Last updated 3 years ago.
- $129,600
- avg. base
Strategic Accounts Manager Salaries at Valeant Pharmaceuticals International
In Wilmington, DE, Strategic Accounts Managers earn $17,241 more than Account Managers, and $25,967 less than Business Development Managers.
Compensation at Valeant Pharmaceuticals International by Department
In Wilmington, DE, The Business Development Department averages $871 more than the Marketing Department, and $3,196 less than the Engineering Department
Strategic Accounts Manager Compensation by Gender (All Companies)
The average female Strategic Accounts Manager at companies similar size to Valeant Pharmaceuticals International reported making $145,283, while the average male Strategic Accounts Manager at similar sized companies reported making $176,168.
Strategic Accounts Manager Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Strategic Accounts Manager at companies similar size to Valeant Pharmaceuticals International reported making $169,167, while the average Hispanic or Latino Strategic Accounts Manager at similar sized companies reported making $110,000.
How Strategic Accounts Managers at Valeant Pharmaceuticals International Rate Their Compensation
The majority of Strategic Accounts Managers at Valeant Pharmaceuticals International believe they're compensated fairly. The vast majority (80%) of Strategic Accounts Managers at Valeant Pharmaceuticals International are satisfied with their benefits. See more compensation ratings at Valeant Pharmaceuticals International
